Development and validation of a prediction model for serious infections in rheumatoid arthritis patients treated with tocilizumab in Japan
The model developed in this study seems to have the potential to inform the risk of SIs in RA patients treated with tocilizumab and may help the early identification of patients at risk of SIs to reduce morbidity and mortality.
Authors
- Mimari Kanazawa (ORCID: https://orcid.org/0000-0003-2243-4267)
- Tomohiro Yamaguchi (ORCID: https://orcid.org/0000-0002-5023-0985)
- S. Takemoto
- Reiko Tanabe (ORCID: https://orcid.org/0009-0009-8321-1113)
- Yuko Furuno
- Shinichi Matsuda (ORCID: https://orcid.org/0000-0003-1822-1090)
- Toshihiro Nanki (ORCID: https://orcid.org/0000-0002-3482-074X)
- Keiko Asao (ORCID: https://orcid.org/0000-0002-2218-060X)
- Naoki Maeda
- Kosei Umetsu
- Tatsuya Kamiuchi
Institutions
- Toho University (JP)
Publication Details
- Journal
- Clinical Rheumatology
- Published
- 2025-02-07
- DOI
- https://doi.org/10.1007/s10067-025-07328-9
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Chugai Pharmaceutical